S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Aimmune TherapeuticsInsmedApellis PharmaceuticalsEidos TherapeuticsAkcea Therapeutics
SymbolNASDAQ:AIMTNASDAQ:INSMNASDAQ:APLSNASDAQ:EIDXNASDAQ:AKCA
Price Information
Current Price$25.45$17.56$28.16$35.42$19.57
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$46.88$38.00$45.14$41.67$36.00
% Upside from Price Target84.18% upside116.40% upside60.31% upside17.64% upside83.96% upside
Trade Information
Market Cap$1.54 billion$1.56 billion$1.79 billion$1.31 billion$1.82 billion
Beta-0.082.970.68-1.051.5
Average Volume716,3511,065,185466,431154,595237,355
Sales & Book Value
Annual RevenueN/A$9.84 millionN/AN/A$64.87 million
Price / SalesN/A159.20N/AN/A28.07
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.09 per share$2.70 per share$2.86 per share$4.22 per share$3.10 per share
Price / BookN/A6.50N/AN/A6.31
Profitability
Net Income$-210,750,000.00$-324,280,000.00$-127,500,000.00$-33,290,000.00$-225,820,000.00
EPS($3.67)($4.17)($2.34)($1.86)($2.74)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-65.62%
Return on Equity (ROE)-89.68%-126.95%-99.71%-30.80%-43.87%
Return on Assets (ROA)-71.14%-47.66%-68.53%-29.42%-35.25%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.24%1.01%0.08%0.01%0.04%
Current Ratio5.80%7.54%8.67%20.89%6.48%
Quick Ratio5.80%7.31%8.67%20.89%6.32%
Ownership Information
Institutional Ownership Percentage78.06%N/A63.51%32.46%25.39%
Insider Ownership Percentage13.75%4.95%10.60%70.10%4.10%
Miscellaneous
Employees2283738728248
Shares Outstanding62.67 million89.21 million63.70 million36.88 million93.03 million
Next Earnings Date11/14/2019 (Estimated)10/29/2019 (Estimated)11/12/2019 (Estimated)11/5/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
 Aimmune TherapeuticsInsmedApellis PharmaceuticalsEidos TherapeuticsAkcea Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel